iBody Announces Collaboration with Novalix to Advance Antibody Drug Discovery

Iwai North America is pleased to share that iBody Inc. has entered into a business alliance with Novalix Japan K.K., bringing together iBody’s proprietary antibody discovery technology and Novalix Group’s drug discovery and antibody evaluation expertise. The collaboration represents an important development for iBody and its antibody discovery platform. Under the alliance, iBody’s proprietary technology […]